Skip to main content
. 2016 Apr 21;7(25):37566–37580. doi: 10.18632/oncotarget.8885

Table 1. Clinical characteristics of the 50 CRC patients and 20 asymptomatic controls.

Clinical features CRC patient Asymptomatic control
(n=50) (n=20)
Sex Male 27 (54%) 9 (45%)
Female 23 (46%) 11 (55%)
Age Median (range) 64 (37-86) 30 (25-48)
CEA Positive rate 16% 0%
iFOBT Positive rate 50% 0%
Tumor Stage 0+I 13 (26%) NA
II 17 (34%) NA
III 19 (38%) NA
IV 1 (2%) NA
Tumor site Right* 14 (28%) NA
Left** 21 (42%) NA
Rectum 15 (30%) NA
Treatment Surgery 50 (100%) NA
Chemotherapy 23 (56%) NA
Radiotherapy 3 (6%) NA
Target therapy 1 (2%) NA
*

Right site = cancer located in the cecum, ascending colon, transverse colon, and hepatic flexture

**

Left site = cancer located in the sigmoid, descending colon, and splenic flexture

NA = not available